Global HER2 ADC Drugs Market Growth 2026-2032
The global HER2 ADC Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The HER2-targeted antibody?drug conjugates (ADCs) trastuzumab emtansine (T-DM1) and trastuzumab deruxtecan (T-DXd) represent a novel class of therapeutics in breast cancer. These drugs augment monoclonal antibodies with a cytotoxic payload, which is attached by a linker, forming the basic structure of an ADC.
United States market for HER2 ADC Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for HER2 ADC Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for HER2 ADC Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key HER2 ADC Drugs players cover Daiichi Sankyo, Genentech, Inc.(Roche), AstraZeneca, RemeGen, MacroGenics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?HER2 ADC Drugs Industry Forecast? looks at past sales and reviews total world HER2 ADC Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected HER2 ADC Drugs sales for 2026 through 2032. With HER2 ADC Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HER2 ADC Drugs industry.
This Insight Report provides a comprehensive analysis of the global HER2 ADC Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HER2 ADC Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global HER2 ADC Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HER2 ADC Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HER2 ADC Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of HER2 ADC Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
The HER2-targeted antibody?drug conjugates (ADCs) trastuzumab emtansine (T-DM1) and trastuzumab deruxtecan (T-DXd) represent a novel class of therapeutics in breast cancer. These drugs augment monoclonal antibodies with a cytotoxic payload, which is attached by a linker, forming the basic structure of an ADC.
United States market for HER2 ADC Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for HER2 ADC Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for HER2 ADC Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key HER2 ADC Drugs players cover Daiichi Sankyo, Genentech, Inc.(Roche), AstraZeneca, RemeGen, MacroGenics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?HER2 ADC Drugs Industry Forecast? looks at past sales and reviews total world HER2 ADC Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected HER2 ADC Drugs sales for 2026 through 2032. With HER2 ADC Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HER2 ADC Drugs industry.
This Insight Report provides a comprehensive analysis of the global HER2 ADC Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HER2 ADC Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global HER2 ADC Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HER2 ADC Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HER2 ADC Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of HER2 ADC Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- T-DM1?Kadcyla?Trastuzumab emtansine?
- T-DXd?DS-8201?Enhertu?Trastuzumab deruxtecan?
- RC48?Disitamab vedotin?
- Hospitals
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Daiichi Sankyo
- Genentech, Inc.(Roche)
- AstraZeneca
- RemeGen
- MacroGenics
- Takeda
- Biokin Pharmaceutical
- BioNTech(Yingen Biopharmaceutical)
- CSPC Pharmaceutical Group
- Hengrui Pharmaceuticals
- What is the 10-year outlook for the global HER2 ADC Drugs market?
- What factors are driving HER2 ADC Drugs market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do HER2 ADC Drugs market opportunities vary by end market size?
- How does HER2 ADC Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global HER2 ADC Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for HER2 ADC Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for HER2 ADC Drugs by Country/Region, 2021, 2025 & 2032
2.2 HER2 ADC Drugs Segment by Type
2.2.1 T-DM1?Kadcyla?Trastuzumab emtansine?
2.2.2 T-DXd?DS-8201?Enhertu?Trastuzumab deruxtecan?
2.2.3 RC48?Disitamab vedotin?
2.2.4 HER2 ADC Drugs Sales by Type
2.2.4.1 Global HER2 ADC Drugs Sales Market Share by Type (2021-2026)
2.2.4.2 Global HER2 ADC Drugs Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global HER2 ADC Drugs Sale Price by Type (2021-2026)
2.3 HER2 ADC Drugs Segment by Application
2.3.1 Hospitals
2.3.2 Clinic
2.3.3 Others
2.3.4 HER2 ADC Drugs Sales by Application
2.3.4.1 Global HER2 ADC Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global HER2 ADC Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global HER2 ADC Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global HER2 ADC Drugs Breakdown Data by Company
3.1.1 Global HER2 ADC Drugs Annual Sales by Company (2021-2026)
3.1.2 Global HER2 ADC Drugs Sales Market Share by Company (2021-2026)
3.2 Global HER2 ADC Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global HER2 ADC Drugs Revenue by Company (2021-2026)
3.2.2 Global HER2 ADC Drugs Revenue Market Share by Company (2021-2026)
3.3 Global HER2 ADC Drugs Sale Price by Company
3.4 Key Manufacturers HER2 ADC Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers HER2 ADC Drugs Product Location Distribution
3.4.2 Players HER2 ADC Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HER2 ADC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic HER2 ADC Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global HER2 ADC Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global HER2 ADC Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic HER2 ADC Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global HER2 ADC Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global HER2 ADC Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas HER2 ADC Drugs Sales Growth
4.4 APAC HER2 ADC Drugs Sales Growth
4.5 Europe HER2 ADC Drugs Sales Growth
4.6 Middle East & Africa HER2 ADC Drugs Sales Growth
5 AMERICAS
5.1 Americas HER2 ADC Drugs Sales by Country
5.1.1 Americas HER2 ADC Drugs Sales by Country (2021-2026)
5.1.2 Americas HER2 ADC Drugs Revenue by Country (2021-2026)
5.2 Americas HER2 ADC Drugs Sales by Type (2021-2026)
5.3 Americas HER2 ADC Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HER2 ADC Drugs Sales by Region
6.1.1 APAC HER2 ADC Drugs Sales by Region (2021-2026)
6.1.2 APAC HER2 ADC Drugs Revenue by Region (2021-2026)
6.2 APAC HER2 ADC Drugs Sales by Type (2021-2026)
6.3 APAC HER2 ADC Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe HER2 ADC Drugs by Country
7.1.1 Europe HER2 ADC Drugs Sales by Country (2021-2026)
7.1.2 Europe HER2 ADC Drugs Revenue by Country (2021-2026)
7.2 Europe HER2 ADC Drugs Sales by Type (2021-2026)
7.3 Europe HER2 ADC Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa HER2 ADC Drugs by Country
8.1.1 Middle East & Africa HER2 ADC Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa HER2 ADC Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa HER2 ADC Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa HER2 ADC Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of HER2 ADC Drugs
10.3 Manufacturing Process Analysis of HER2 ADC Drugs
10.4 Industry Chain Structure of HER2 ADC Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 HER2 ADC Drugs Distributors
11.3 HER2 ADC Drugs Customer
12 WORLD FORECAST REVIEW FOR HER2 ADC DRUGS BY GEOGRAPHIC REGION
12.1 Global HER2 ADC Drugs Market Size Forecast by Region
12.1.1 Global HER2 ADC Drugs Forecast by Region (2027-2032)
12.1.2 Global HER2 ADC Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global HER2 ADC Drugs Forecast by Type (2027-2032)
12.7 Global HER2 ADC Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Daiichi Sankyo
13.1.1 Daiichi Sankyo Company Information
13.1.2 Daiichi Sankyo HER2 ADC Drugs Product Portfolios and Specifications
13.1.3 Daiichi Sankyo HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Daiichi Sankyo Main Business Overview
13.1.5 Daiichi Sankyo Latest Developments
13.2 Genentech, Inc.(Roche)
13.2.1 Genentech, Inc.(Roche) Company Information
13.2.2 Genentech, Inc.(Roche) HER2 ADC Drugs Product Portfolios and Specifications
13.2.3 Genentech, Inc.(Roche) HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Genentech, Inc.(Roche) Main Business Overview
13.2.5 Genentech, Inc.(Roche) Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca HER2 ADC Drugs Product Portfolios and Specifications
13.3.3 AstraZeneca HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 RemeGen
13.4.1 RemeGen Company Information
13.4.2 RemeGen HER2 ADC Drugs Product Portfolios and Specifications
13.4.3 RemeGen HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 RemeGen Main Business Overview
13.4.5 RemeGen Latest Developments
13.5 MacroGenics
13.5.1 MacroGenics Company Information
13.5.2 MacroGenics HER2 ADC Drugs Product Portfolios and Specifications
13.5.3 MacroGenics HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 MacroGenics Main Business Overview
13.5.5 MacroGenics Latest Developments
13.6 Takeda
13.6.1 Takeda Company Information
13.6.2 Takeda HER2 ADC Drugs Product Portfolios and Specifications
13.6.3 Takeda HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Takeda Main Business Overview
13.6.5 Takeda Latest Developments
13.7 Biokin Pharmaceutical
13.7.1 Biokin Pharmaceutical Company Information
13.7.2 Biokin Pharmaceutical HER2 ADC Drugs Product Portfolios and Specifications
13.7.3 Biokin Pharmaceutical HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Biokin Pharmaceutical Main Business Overview
13.7.5 Biokin Pharmaceutical Latest Developments
13.8 BioNTech(Yingen Biopharmaceutical)
13.8.1 BioNTech(Yingen Biopharmaceutical) Company Information
13.8.2 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product Portfolios and Specifications
13.8.3 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 BioNTech(Yingen Biopharmaceutical) Main Business Overview
13.8.5 BioNTech(Yingen Biopharmaceutical) Latest Developments
13.9 CSPC Pharmaceutical Group
13.9.1 CSPC Pharmaceutical Group Company Information
13.9.2 CSPC Pharmaceutical Group HER2 ADC Drugs Product Portfolios and Specifications
13.9.3 CSPC Pharmaceutical Group HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 CSPC Pharmaceutical Group Main Business Overview
13.9.5 CSPC Pharmaceutical Group Latest Developments
13.10 Hengrui Pharmaceuticals
13.10.1 Hengrui Pharmaceuticals Company Information
13.10.2 Hengrui Pharmaceuticals HER2 ADC Drugs Product Portfolios and Specifications
13.10.3 Hengrui Pharmaceuticals HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Hengrui Pharmaceuticals Main Business Overview
13.10.5 Hengrui Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global HER2 ADC Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for HER2 ADC Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for HER2 ADC Drugs by Country/Region, 2021, 2025 & 2032
2.2 HER2 ADC Drugs Segment by Type
2.2.1 T-DM1?Kadcyla?Trastuzumab emtansine?
2.2.2 T-DXd?DS-8201?Enhertu?Trastuzumab deruxtecan?
2.2.3 RC48?Disitamab vedotin?
2.2.4 HER2 ADC Drugs Sales by Type
2.2.4.1 Global HER2 ADC Drugs Sales Market Share by Type (2021-2026)
2.2.4.2 Global HER2 ADC Drugs Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global HER2 ADC Drugs Sale Price by Type (2021-2026)
2.3 HER2 ADC Drugs Segment by Application
2.3.1 Hospitals
2.3.2 Clinic
2.3.3 Others
2.3.4 HER2 ADC Drugs Sales by Application
2.3.4.1 Global HER2 ADC Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global HER2 ADC Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global HER2 ADC Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global HER2 ADC Drugs Breakdown Data by Company
3.1.1 Global HER2 ADC Drugs Annual Sales by Company (2021-2026)
3.1.2 Global HER2 ADC Drugs Sales Market Share by Company (2021-2026)
3.2 Global HER2 ADC Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global HER2 ADC Drugs Revenue by Company (2021-2026)
3.2.2 Global HER2 ADC Drugs Revenue Market Share by Company (2021-2026)
3.3 Global HER2 ADC Drugs Sale Price by Company
3.4 Key Manufacturers HER2 ADC Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers HER2 ADC Drugs Product Location Distribution
3.4.2 Players HER2 ADC Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HER2 ADC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic HER2 ADC Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global HER2 ADC Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global HER2 ADC Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic HER2 ADC Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global HER2 ADC Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global HER2 ADC Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas HER2 ADC Drugs Sales Growth
4.4 APAC HER2 ADC Drugs Sales Growth
4.5 Europe HER2 ADC Drugs Sales Growth
4.6 Middle East & Africa HER2 ADC Drugs Sales Growth
5 AMERICAS
5.1 Americas HER2 ADC Drugs Sales by Country
5.1.1 Americas HER2 ADC Drugs Sales by Country (2021-2026)
5.1.2 Americas HER2 ADC Drugs Revenue by Country (2021-2026)
5.2 Americas HER2 ADC Drugs Sales by Type (2021-2026)
5.3 Americas HER2 ADC Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HER2 ADC Drugs Sales by Region
6.1.1 APAC HER2 ADC Drugs Sales by Region (2021-2026)
6.1.2 APAC HER2 ADC Drugs Revenue by Region (2021-2026)
6.2 APAC HER2 ADC Drugs Sales by Type (2021-2026)
6.3 APAC HER2 ADC Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe HER2 ADC Drugs by Country
7.1.1 Europe HER2 ADC Drugs Sales by Country (2021-2026)
7.1.2 Europe HER2 ADC Drugs Revenue by Country (2021-2026)
7.2 Europe HER2 ADC Drugs Sales by Type (2021-2026)
7.3 Europe HER2 ADC Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa HER2 ADC Drugs by Country
8.1.1 Middle East & Africa HER2 ADC Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa HER2 ADC Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa HER2 ADC Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa HER2 ADC Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of HER2 ADC Drugs
10.3 Manufacturing Process Analysis of HER2 ADC Drugs
10.4 Industry Chain Structure of HER2 ADC Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 HER2 ADC Drugs Distributors
11.3 HER2 ADC Drugs Customer
12 WORLD FORECAST REVIEW FOR HER2 ADC DRUGS BY GEOGRAPHIC REGION
12.1 Global HER2 ADC Drugs Market Size Forecast by Region
12.1.1 Global HER2 ADC Drugs Forecast by Region (2027-2032)
12.1.2 Global HER2 ADC Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global HER2 ADC Drugs Forecast by Type (2027-2032)
12.7 Global HER2 ADC Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Daiichi Sankyo
13.1.1 Daiichi Sankyo Company Information
13.1.2 Daiichi Sankyo HER2 ADC Drugs Product Portfolios and Specifications
13.1.3 Daiichi Sankyo HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Daiichi Sankyo Main Business Overview
13.1.5 Daiichi Sankyo Latest Developments
13.2 Genentech, Inc.(Roche)
13.2.1 Genentech, Inc.(Roche) Company Information
13.2.2 Genentech, Inc.(Roche) HER2 ADC Drugs Product Portfolios and Specifications
13.2.3 Genentech, Inc.(Roche) HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Genentech, Inc.(Roche) Main Business Overview
13.2.5 Genentech, Inc.(Roche) Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca HER2 ADC Drugs Product Portfolios and Specifications
13.3.3 AstraZeneca HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 RemeGen
13.4.1 RemeGen Company Information
13.4.2 RemeGen HER2 ADC Drugs Product Portfolios and Specifications
13.4.3 RemeGen HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 RemeGen Main Business Overview
13.4.5 RemeGen Latest Developments
13.5 MacroGenics
13.5.1 MacroGenics Company Information
13.5.2 MacroGenics HER2 ADC Drugs Product Portfolios and Specifications
13.5.3 MacroGenics HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 MacroGenics Main Business Overview
13.5.5 MacroGenics Latest Developments
13.6 Takeda
13.6.1 Takeda Company Information
13.6.2 Takeda HER2 ADC Drugs Product Portfolios and Specifications
13.6.3 Takeda HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Takeda Main Business Overview
13.6.5 Takeda Latest Developments
13.7 Biokin Pharmaceutical
13.7.1 Biokin Pharmaceutical Company Information
13.7.2 Biokin Pharmaceutical HER2 ADC Drugs Product Portfolios and Specifications
13.7.3 Biokin Pharmaceutical HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Biokin Pharmaceutical Main Business Overview
13.7.5 Biokin Pharmaceutical Latest Developments
13.8 BioNTech(Yingen Biopharmaceutical)
13.8.1 BioNTech(Yingen Biopharmaceutical) Company Information
13.8.2 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product Portfolios and Specifications
13.8.3 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 BioNTech(Yingen Biopharmaceutical) Main Business Overview
13.8.5 BioNTech(Yingen Biopharmaceutical) Latest Developments
13.9 CSPC Pharmaceutical Group
13.9.1 CSPC Pharmaceutical Group Company Information
13.9.2 CSPC Pharmaceutical Group HER2 ADC Drugs Product Portfolios and Specifications
13.9.3 CSPC Pharmaceutical Group HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 CSPC Pharmaceutical Group Main Business Overview
13.9.5 CSPC Pharmaceutical Group Latest Developments
13.10 Hengrui Pharmaceuticals
13.10.1 Hengrui Pharmaceuticals Company Information
13.10.2 Hengrui Pharmaceuticals HER2 ADC Drugs Product Portfolios and Specifications
13.10.3 Hengrui Pharmaceuticals HER2 ADC Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Hengrui Pharmaceuticals Main Business Overview
13.10.5 Hengrui Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. HER2 ADC Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. HER2 ADC Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of T-DM1?Kadcyla?Trastuzumab emtansine?
Table 4. Major Players of T-DXd?DS-8201?Enhertu?Trastuzumab deruxtecan?
Table 5. Major Players of RC48?Disitamab vedotin?
Table 6. Global HER2 ADC Drugs Sales by Type (2021-2026) & (kg)
Table 7. Global HER2 ADC Drugs Sales Market Share by Type (2021-2026)
Table 8. Global HER2 ADC Drugs Revenue by Type (2021-2026) & ($ million)
Table 9. Global HER2 ADC Drugs Revenue Market Share by Type (2021-2026)
Table 10. Global HER2 ADC Drugs Sale Price by Type (2021-2026) & (US$/kg)
Table 11. Global HER2 ADC Drugs Sale by Application (2021-2026) & (kg)
Table 12. Global HER2 ADC Drugs Sale Market Share by Application (2021-2026)
Table 13. Global HER2 ADC Drugs Revenue by Application (2021-2026) & ($ million)
Table 14. Global HER2 ADC Drugs Revenue Market Share by Application (2021-2026)
Table 15. Global HER2 ADC Drugs Sale Price by Application (2021-2026) & (US$/kg)
Table 16. Global HER2 ADC Drugs Sales by Company (2021-2026) & (kg)
Table 17. Global HER2 ADC Drugs Sales Market Share by Company (2021-2026)
Table 18. Global HER2 ADC Drugs Revenue by Company (2021-2026) & ($ millions)
Table 19. Global HER2 ADC Drugs Revenue Market Share by Company (2021-2026)
Table 20. Global HER2 ADC Drugs Sale Price by Company (2021-2026) & (US$/kg)
Table 21. Key Manufacturers HER2 ADC Drugs Producing Area Distribution and Sales Area
Table 22. Players HER2 ADC Drugs Products Offered
Table 23. HER2 ADC Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global HER2 ADC Drugs Sales by Geographic Region (2021-2026) & (kg)
Table 27. Global HER2 ADC Drugs Sales Market Share Geographic Region (2021-2026)
Table 28. Global HER2 ADC Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global HER2 ADC Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global HER2 ADC Drugs Sales by Country/Region (2021-2026) & (kg)
Table 31. Global HER2 ADC Drugs Sales Market Share by Country/Region (2021-2026)
Table 32. Global HER2 ADC Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global HER2 ADC Drugs Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas HER2 ADC Drugs Sales by Country (2021-2026) & (kg)
Table 35. Americas HER2 ADC Drugs Sales Market Share by Country (2021-2026)
Table 36. Americas HER2 ADC Drugs Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas HER2 ADC Drugs Sales by Type (2021-2026) & (kg)
Table 38. Americas HER2 ADC Drugs Sales by Application (2021-2026) & (kg)
Table 39. APAC HER2 ADC Drugs Sales by Region (2021-2026) & (kg)
Table 40. APAC HER2 ADC Drugs Sales Market Share by Region (2021-2026)
Table 41. APAC HER2 ADC Drugs Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC HER2 ADC Drugs Sales by Type (2021-2026) & (kg)
Table 43. APAC HER2 ADC Drugs Sales by Application (2021-2026) & (kg)
Table 44. Europe HER2 ADC Drugs Sales by Country (2021-2026) & (kg)
Table 45. Europe HER2 ADC Drugs Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe HER2 ADC Drugs Sales by Type (2021-2026) & (kg)
Table 47. Europe HER2 ADC Drugs Sales by Application (2021-2026) & (kg)
Table 48. Middle East & Africa HER2 ADC Drugs Sales by Country (2021-2026) & (kg)
Table 49. Middle East & Africa HER2 ADC Drugs Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa HER2 ADC Drugs Sales by Type (2021-2026) & (kg)
Table 51. Middle East & Africa HER2 ADC Drugs Sales by Application (2021-2026) & (kg)
Table 52. Key Market Drivers & Growth Opportunities of HER2 ADC Drugs
Table 53. Key Market Challenges & Risks of HER2 ADC Drugs
Table 54. Key Industry Trends of HER2 ADC Drugs
Table 55. HER2 ADC Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. HER2 ADC Drugs Distributors List
Table 58. HER2 ADC Drugs Customer List
Table 59. Global HER2 ADC Drugs Sales Forecast by Region (2027-2032) & (kg)
Table 60. Global HER2 ADC Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas HER2 ADC Drugs Sales Forecast by Country (2027-2032) & (kg)
Table 62. Americas HER2 ADC Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC HER2 ADC Drugs Sales Forecast by Region (2027-2032) & (kg)
Table 64. APAC HER2 ADC Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe HER2 ADC Drugs Sales Forecast by Country (2027-2032) & (kg)
Table 66. Europe HER2 ADC Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa HER2 ADC Drugs Sales Forecast by Country (2027-2032) & (kg)
Table 68. Middle East & Africa HER2 ADC Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global HER2 ADC Drugs Sales Forecast by Type (2027-2032) & (kg)
Table 70. Global HER2 ADC Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global HER2 ADC Drugs Sales Forecast by Application (2027-2032) & (kg)
Table 72. Global HER2 ADC Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Daiichi Sankyo Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Daiichi Sankyo HER2 ADC Drugs Product Portfolios and Specifications
Table 75. Daiichi Sankyo HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 76. Daiichi Sankyo Main Business
Table 77. Daiichi Sankyo Latest Developments
Table 78. Genentech, Inc.(Roche) Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Genentech, Inc.(Roche) HER2 ADC Drugs Product Portfolios and Specifications
Table 80. Genentech, Inc.(Roche) HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 81. Genentech, Inc.(Roche) Main Business
Table 82. Genentech, Inc.(Roche) Latest Developments
Table 83. AstraZeneca Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. AstraZeneca HER2 ADC Drugs Product Portfolios and Specifications
Table 85. AstraZeneca HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 86. AstraZeneca Main Business
Table 87. AstraZeneca Latest Developments
Table 88. RemeGen Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. RemeGen HER2 ADC Drugs Product Portfolios and Specifications
Table 90. RemeGen HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 91. RemeGen Main Business
Table 92. RemeGen Latest Developments
Table 93. MacroGenics Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. MacroGenics HER2 ADC Drugs Product Portfolios and Specifications
Table 95. MacroGenics HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 96. MacroGenics Main Business
Table 97. MacroGenics Latest Developments
Table 98. Takeda Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Takeda HER2 ADC Drugs Product Portfolios and Specifications
Table 100. Takeda HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 101. Takeda Main Business
Table 102. Takeda Latest Developments
Table 103. Biokin Pharmaceutical Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Biokin Pharmaceutical HER2 ADC Drugs Product Portfolios and Specifications
Table 105. Biokin Pharmaceutical HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 106. Biokin Pharmaceutical Main Business
Table 107. Biokin Pharmaceutical Latest Developments
Table 108. BioNTech(Yingen Biopharmaceutical) Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product Portfolios and Specifications
Table 110. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 111. BioNTech(Yingen Biopharmaceutical) Main Business
Table 112. BioNTech(Yingen Biopharmaceutical) Latest Developments
Table 113. CSPC Pharmaceutical Group Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. CSPC Pharmaceutical Group HER2 ADC Drugs Product Portfolios and Specifications
Table 115. CSPC Pharmaceutical Group HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 116. CSPC Pharmaceutical Group Main Business
Table 117. CSPC Pharmaceutical Group Latest Developments
Table 118. Hengrui Pharmaceuticals Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Hengrui Pharmaceuticals HER2 ADC Drugs Product Portfolios and Specifications
Table 120. Hengrui Pharmaceuticals HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 121. Hengrui Pharmaceuticals Main Business
Table 122. Hengrui Pharmaceuticals Latest Developments
Table 1. HER2 ADC Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. HER2 ADC Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of T-DM1?Kadcyla?Trastuzumab emtansine?
Table 4. Major Players of T-DXd?DS-8201?Enhertu?Trastuzumab deruxtecan?
Table 5. Major Players of RC48?Disitamab vedotin?
Table 6. Global HER2 ADC Drugs Sales by Type (2021-2026) & (kg)
Table 7. Global HER2 ADC Drugs Sales Market Share by Type (2021-2026)
Table 8. Global HER2 ADC Drugs Revenue by Type (2021-2026) & ($ million)
Table 9. Global HER2 ADC Drugs Revenue Market Share by Type (2021-2026)
Table 10. Global HER2 ADC Drugs Sale Price by Type (2021-2026) & (US$/kg)
Table 11. Global HER2 ADC Drugs Sale by Application (2021-2026) & (kg)
Table 12. Global HER2 ADC Drugs Sale Market Share by Application (2021-2026)
Table 13. Global HER2 ADC Drugs Revenue by Application (2021-2026) & ($ million)
Table 14. Global HER2 ADC Drugs Revenue Market Share by Application (2021-2026)
Table 15. Global HER2 ADC Drugs Sale Price by Application (2021-2026) & (US$/kg)
Table 16. Global HER2 ADC Drugs Sales by Company (2021-2026) & (kg)
Table 17. Global HER2 ADC Drugs Sales Market Share by Company (2021-2026)
Table 18. Global HER2 ADC Drugs Revenue by Company (2021-2026) & ($ millions)
Table 19. Global HER2 ADC Drugs Revenue Market Share by Company (2021-2026)
Table 20. Global HER2 ADC Drugs Sale Price by Company (2021-2026) & (US$/kg)
Table 21. Key Manufacturers HER2 ADC Drugs Producing Area Distribution and Sales Area
Table 22. Players HER2 ADC Drugs Products Offered
Table 23. HER2 ADC Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global HER2 ADC Drugs Sales by Geographic Region (2021-2026) & (kg)
Table 27. Global HER2 ADC Drugs Sales Market Share Geographic Region (2021-2026)
Table 28. Global HER2 ADC Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global HER2 ADC Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global HER2 ADC Drugs Sales by Country/Region (2021-2026) & (kg)
Table 31. Global HER2 ADC Drugs Sales Market Share by Country/Region (2021-2026)
Table 32. Global HER2 ADC Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global HER2 ADC Drugs Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas HER2 ADC Drugs Sales by Country (2021-2026) & (kg)
Table 35. Americas HER2 ADC Drugs Sales Market Share by Country (2021-2026)
Table 36. Americas HER2 ADC Drugs Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas HER2 ADC Drugs Sales by Type (2021-2026) & (kg)
Table 38. Americas HER2 ADC Drugs Sales by Application (2021-2026) & (kg)
Table 39. APAC HER2 ADC Drugs Sales by Region (2021-2026) & (kg)
Table 40. APAC HER2 ADC Drugs Sales Market Share by Region (2021-2026)
Table 41. APAC HER2 ADC Drugs Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC HER2 ADC Drugs Sales by Type (2021-2026) & (kg)
Table 43. APAC HER2 ADC Drugs Sales by Application (2021-2026) & (kg)
Table 44. Europe HER2 ADC Drugs Sales by Country (2021-2026) & (kg)
Table 45. Europe HER2 ADC Drugs Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe HER2 ADC Drugs Sales by Type (2021-2026) & (kg)
Table 47. Europe HER2 ADC Drugs Sales by Application (2021-2026) & (kg)
Table 48. Middle East & Africa HER2 ADC Drugs Sales by Country (2021-2026) & (kg)
Table 49. Middle East & Africa HER2 ADC Drugs Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa HER2 ADC Drugs Sales by Type (2021-2026) & (kg)
Table 51. Middle East & Africa HER2 ADC Drugs Sales by Application (2021-2026) & (kg)
Table 52. Key Market Drivers & Growth Opportunities of HER2 ADC Drugs
Table 53. Key Market Challenges & Risks of HER2 ADC Drugs
Table 54. Key Industry Trends of HER2 ADC Drugs
Table 55. HER2 ADC Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. HER2 ADC Drugs Distributors List
Table 58. HER2 ADC Drugs Customer List
Table 59. Global HER2 ADC Drugs Sales Forecast by Region (2027-2032) & (kg)
Table 60. Global HER2 ADC Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas HER2 ADC Drugs Sales Forecast by Country (2027-2032) & (kg)
Table 62. Americas HER2 ADC Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC HER2 ADC Drugs Sales Forecast by Region (2027-2032) & (kg)
Table 64. APAC HER2 ADC Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe HER2 ADC Drugs Sales Forecast by Country (2027-2032) & (kg)
Table 66. Europe HER2 ADC Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa HER2 ADC Drugs Sales Forecast by Country (2027-2032) & (kg)
Table 68. Middle East & Africa HER2 ADC Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global HER2 ADC Drugs Sales Forecast by Type (2027-2032) & (kg)
Table 70. Global HER2 ADC Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global HER2 ADC Drugs Sales Forecast by Application (2027-2032) & (kg)
Table 72. Global HER2 ADC Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Daiichi Sankyo Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Daiichi Sankyo HER2 ADC Drugs Product Portfolios and Specifications
Table 75. Daiichi Sankyo HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 76. Daiichi Sankyo Main Business
Table 77. Daiichi Sankyo Latest Developments
Table 78. Genentech, Inc.(Roche) Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Genentech, Inc.(Roche) HER2 ADC Drugs Product Portfolios and Specifications
Table 80. Genentech, Inc.(Roche) HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 81. Genentech, Inc.(Roche) Main Business
Table 82. Genentech, Inc.(Roche) Latest Developments
Table 83. AstraZeneca Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. AstraZeneca HER2 ADC Drugs Product Portfolios and Specifications
Table 85. AstraZeneca HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 86. AstraZeneca Main Business
Table 87. AstraZeneca Latest Developments
Table 88. RemeGen Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. RemeGen HER2 ADC Drugs Product Portfolios and Specifications
Table 90. RemeGen HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 91. RemeGen Main Business
Table 92. RemeGen Latest Developments
Table 93. MacroGenics Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. MacroGenics HER2 ADC Drugs Product Portfolios and Specifications
Table 95. MacroGenics HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 96. MacroGenics Main Business
Table 97. MacroGenics Latest Developments
Table 98. Takeda Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Takeda HER2 ADC Drugs Product Portfolios and Specifications
Table 100. Takeda HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 101. Takeda Main Business
Table 102. Takeda Latest Developments
Table 103. Biokin Pharmaceutical Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Biokin Pharmaceutical HER2 ADC Drugs Product Portfolios and Specifications
Table 105. Biokin Pharmaceutical HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 106. Biokin Pharmaceutical Main Business
Table 107. Biokin Pharmaceutical Latest Developments
Table 108. BioNTech(Yingen Biopharmaceutical) Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product Portfolios and Specifications
Table 110. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 111. BioNTech(Yingen Biopharmaceutical) Main Business
Table 112. BioNTech(Yingen Biopharmaceutical) Latest Developments
Table 113. CSPC Pharmaceutical Group Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. CSPC Pharmaceutical Group HER2 ADC Drugs Product Portfolios and Specifications
Table 115. CSPC Pharmaceutical Group HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 116. CSPC Pharmaceutical Group Main Business
Table 117. CSPC Pharmaceutical Group Latest Developments
Table 118. Hengrui Pharmaceuticals Basic Information, HER2 ADC Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Hengrui Pharmaceuticals HER2 ADC Drugs Product Portfolios and Specifications
Table 120. Hengrui Pharmaceuticals HER2 ADC Drugs Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 121. Hengrui Pharmaceuticals Main Business
Table 122. Hengrui Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of HER2 ADC Drugs
Figure 2. HER2 ADC Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global HER2 ADC Drugs Sales Growth Rate 2021-2032 (kg)
Figure 7. Global HER2 ADC Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. HER2 ADC Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. HER2 ADC Drugs Sales Market Share by Country/Region (2025)
Figure 10. HER2 ADC Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of T-DM1?Kadcyla?Trastuzumab emtansine?
Figure 12. Product Picture of T-DXd?DS-8201?Enhertu?Trastuzumab deruxtecan?
Figure 13. Product Picture of RC48?Disitamab vedotin?
Figure 14. Global HER2 ADC Drugs Sales Market Share by Type in 2026
Figure 15. Global HER2 ADC Drugs Revenue Market Share by Type (2021-2026)
Figure 16. HER2 ADC Drugs Consumed in Hospitals
Figure 17. Global HER2 ADC Drugs Market: Hospitals (2021-2026) & (kg)
Figure 18. HER2 ADC Drugs Consumed in Clinic
Figure 19. Global HER2 ADC Drugs Market: Clinic (2021-2026) & (kg)
Figure 20. HER2 ADC Drugs Consumed in Others
Figure 21. Global HER2 ADC Drugs Market: Others (2021-2026) & (kg)
Figure 22. Global HER2 ADC Drugs Sale Market Share by Application (2025)
Figure 23. Global HER2 ADC Drugs Revenue Market Share by Application in 2026
Figure 24. HER2 ADC Drugs Sales by Company in 2026 (kg)
Figure 25. Global HER2 ADC Drugs Sales Market Share by Company in 2026
Figure 26. HER2 ADC Drugs Revenue by Company in 2026 ($ millions)
Figure 27. Global HER2 ADC Drugs Revenue Market Share by Company in 2026
Figure 28. Global HER2 ADC Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global HER2 ADC Drugs Revenue Market Share by Geographic Region in 2026
Figure 30. Americas HER2 ADC Drugs Sales 2021-2026 (kg)
Figure 31. Americas HER2 ADC Drugs Revenue 2021-2026 ($ millions)
Figure 32. APAC HER2 ADC Drugs Sales 2021-2026 (kg)
Figure 33. APAC HER2 ADC Drugs Revenue 2021-2026 ($ millions)
Figure 34. Europe HER2 ADC Drugs Sales 2021-2026 (kg)
Figure 35. Europe HER2 ADC Drugs Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa HER2 ADC Drugs Sales 2021-2026 (kg)
Figure 37. Middle East & Africa HER2 ADC Drugs Revenue 2021-2026 ($ millions)
Figure 38. Americas HER2 ADC Drugs Sales Market Share by Country in 2026
Figure 39. Americas HER2 ADC Drugs Revenue Market Share by Country (2021-2026)
Figure 40. Americas HER2 ADC Drugs Sales Market Share by Type (2021-2026)
Figure 41. Americas HER2 ADC Drugs Sales Market Share by Application (2021-2026)
Figure 42. United States HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC HER2 ADC Drugs Sales Market Share by Region in 2026
Figure 47. APAC HER2 ADC Drugs Revenue Market Share by Region (2021-2026)
Figure 48. APAC HER2 ADC Drugs Sales Market Share by Type (2021-2026)
Figure 49. APAC HER2 ADC Drugs Sales Market Share by Application (2021-2026)
Figure 50. China HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. India HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe HER2 ADC Drugs Sales Market Share by Country in 2026
Figure 58. Europe HER2 ADC Drugs Revenue Market Share by Country (2021-2026)
Figure 59. Europe HER2 ADC Drugs Sales Market Share by Type (2021-2026)
Figure 60. Europe HER2 ADC Drugs Sales Market Share by Application (2021-2026)
Figure 61. Germany HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. France HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. UK HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa HER2 ADC Drugs Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa HER2 ADC Drugs Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa HER2 ADC Drugs Sales Market Share by Application (2021-2026)
Figure 69. Egypt HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of HER2 ADC Drugs in 2026
Figure 75. Manufacturing Process Analysis of HER2 ADC Drugs
Figure 76. Industry Chain Structure of HER2 ADC Drugs
Figure 77. Channels of Distribution
Figure 78. Global HER2 ADC Drugs Sales Market Forecast by Region (2027-2032)
Figure 79. Global HER2 ADC Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global HER2 ADC Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global HER2 ADC Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global HER2 ADC Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global HER2 ADC Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of HER2 ADC Drugs
Figure 2. HER2 ADC Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global HER2 ADC Drugs Sales Growth Rate 2021-2032 (kg)
Figure 7. Global HER2 ADC Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. HER2 ADC Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. HER2 ADC Drugs Sales Market Share by Country/Region (2025)
Figure 10. HER2 ADC Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of T-DM1?Kadcyla?Trastuzumab emtansine?
Figure 12. Product Picture of T-DXd?DS-8201?Enhertu?Trastuzumab deruxtecan?
Figure 13. Product Picture of RC48?Disitamab vedotin?
Figure 14. Global HER2 ADC Drugs Sales Market Share by Type in 2026
Figure 15. Global HER2 ADC Drugs Revenue Market Share by Type (2021-2026)
Figure 16. HER2 ADC Drugs Consumed in Hospitals
Figure 17. Global HER2 ADC Drugs Market: Hospitals (2021-2026) & (kg)
Figure 18. HER2 ADC Drugs Consumed in Clinic
Figure 19. Global HER2 ADC Drugs Market: Clinic (2021-2026) & (kg)
Figure 20. HER2 ADC Drugs Consumed in Others
Figure 21. Global HER2 ADC Drugs Market: Others (2021-2026) & (kg)
Figure 22. Global HER2 ADC Drugs Sale Market Share by Application (2025)
Figure 23. Global HER2 ADC Drugs Revenue Market Share by Application in 2026
Figure 24. HER2 ADC Drugs Sales by Company in 2026 (kg)
Figure 25. Global HER2 ADC Drugs Sales Market Share by Company in 2026
Figure 26. HER2 ADC Drugs Revenue by Company in 2026 ($ millions)
Figure 27. Global HER2 ADC Drugs Revenue Market Share by Company in 2026
Figure 28. Global HER2 ADC Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global HER2 ADC Drugs Revenue Market Share by Geographic Region in 2026
Figure 30. Americas HER2 ADC Drugs Sales 2021-2026 (kg)
Figure 31. Americas HER2 ADC Drugs Revenue 2021-2026 ($ millions)
Figure 32. APAC HER2 ADC Drugs Sales 2021-2026 (kg)
Figure 33. APAC HER2 ADC Drugs Revenue 2021-2026 ($ millions)
Figure 34. Europe HER2 ADC Drugs Sales 2021-2026 (kg)
Figure 35. Europe HER2 ADC Drugs Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa HER2 ADC Drugs Sales 2021-2026 (kg)
Figure 37. Middle East & Africa HER2 ADC Drugs Revenue 2021-2026 ($ millions)
Figure 38. Americas HER2 ADC Drugs Sales Market Share by Country in 2026
Figure 39. Americas HER2 ADC Drugs Revenue Market Share by Country (2021-2026)
Figure 40. Americas HER2 ADC Drugs Sales Market Share by Type (2021-2026)
Figure 41. Americas HER2 ADC Drugs Sales Market Share by Application (2021-2026)
Figure 42. United States HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC HER2 ADC Drugs Sales Market Share by Region in 2026
Figure 47. APAC HER2 ADC Drugs Revenue Market Share by Region (2021-2026)
Figure 48. APAC HER2 ADC Drugs Sales Market Share by Type (2021-2026)
Figure 49. APAC HER2 ADC Drugs Sales Market Share by Application (2021-2026)
Figure 50. China HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. India HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe HER2 ADC Drugs Sales Market Share by Country in 2026
Figure 58. Europe HER2 ADC Drugs Revenue Market Share by Country (2021-2026)
Figure 59. Europe HER2 ADC Drugs Sales Market Share by Type (2021-2026)
Figure 60. Europe HER2 ADC Drugs Sales Market Share by Application (2021-2026)
Figure 61. Germany HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. France HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. UK HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa HER2 ADC Drugs Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa HER2 ADC Drugs Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa HER2 ADC Drugs Sales Market Share by Application (2021-2026)
Figure 69. Egypt HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries HER2 ADC Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of HER2 ADC Drugs in 2026
Figure 75. Manufacturing Process Analysis of HER2 ADC Drugs
Figure 76. Industry Chain Structure of HER2 ADC Drugs
Figure 77. Channels of Distribution
Figure 78. Global HER2 ADC Drugs Sales Market Forecast by Region (2027-2032)
Figure 79. Global HER2 ADC Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global HER2 ADC Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global HER2 ADC Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global HER2 ADC Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global HER2 ADC Drugs Revenue Market Share Forecast by Application (2027-2032)
